Annual Accounts Payable
$26.03 M
+$8.11 M+45.23%
31 December 2023
Summary:
Ionis Pharmaceuticals annual accounts payable is currently $26.03 million, with the most recent change of +$8.11 million (+45.23%) on 31 December 2023. During the last 3 years, it has risen by +$8.83 million (+51.33%). IONS annual accounts payable is now -9.19% below its all-time high of $28.66 million, reached on 31 December 2018.IONS Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$9.05 M
-$191.00 K-2.07%
30 September 2024
Summary:
Ionis Pharmaceuticals quarterly accounts payable is currently $9.05 million, with the most recent change of -$191.00 thousand (-2.07%) on 30 September 2024. Over the past year, it has increased by +$3.44 million (+61.21%). IONS quarterly accounts payable is now -68.42% below its all-time high of $28.66 million, reached on 31 December 2018.IONS Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IONS Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +45.2% | +61.2% |
| 3 y3 years | +51.3% | +8.3% |
| 5 y5 years | -9.2% | -31.1% |
IONS Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +118.6% | -65.2% | +61.2% |
| 5 y | 5 years | -9.2% | +118.6% | -65.2% | +61.2% |
| alltime | all time | -9.2% | +2502.7% | -68.4% | +2163.0% |
Ionis Pharmaceuticals Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $9.05 M(-2.1%) |
| June 2024 | - | $9.24 M(-29.3%) |
| Mar 2024 | - | $13.08 M(-49.7%) |
| Dec 2023 | $26.03 M(+45.2%) | $26.03 M(+363.5%) |
| Sept 2023 | - | $5.62 M(-76.6%) |
| June 2023 | - | $24.02 M(+128.8%) |
| Mar 2023 | - | $10.50 M(-41.4%) |
| Dec 2022 | $17.92 M(+50.5%) | $17.92 M(-12.8%) |
| Sept 2022 | - | $20.55 M(+98.5%) |
| June 2022 | - | $10.35 M(-35.8%) |
| Mar 2022 | - | $16.13 M(+35.5%) |
| Dec 2021 | $11.90 M(-30.8%) | $11.90 M(+42.4%) |
| Sept 2021 | - | $8.36 M(-43.0%) |
| June 2021 | - | $14.66 M(+54.2%) |
| Mar 2021 | - | $9.51 M(-44.7%) |
| Dec 2020 | $17.20 M(+7.0%) | $17.20 M(+6.0%) |
| Sept 2020 | - | $16.22 M(+119.0%) |
| June 2020 | - | $7.41 M(-65.0%) |
| Mar 2020 | - | $21.17 M(+31.8%) |
| Dec 2019 | $16.07 M(-43.9%) | $16.07 M(+22.2%) |
| Sept 2019 | - | $13.15 M(-15.9%) |
| June 2019 | - | $15.63 M(+17.2%) |
| Mar 2019 | - | $13.33 M(-53.5%) |
| Dec 2018 | $28.66 M(+15.2%) | $28.66 M(+111.1%) |
| Sept 2018 | - | $13.58 M(+2.1%) |
| June 2018 | - | $13.29 M(-3.9%) |
| Mar 2018 | - | $13.83 M(-44.4%) |
| Dec 2017 | $24.89 M(+17.8%) | $24.89 M(+5.8%) |
| Sept 2017 | - | $23.52 M(+77.3%) |
| June 2017 | - | $13.27 M(-42.9%) |
| Mar 2017 | - | $23.24 M(+10.0%) |
| Dec 2016 | $21.12 M(-25.5%) | $21.12 M(+34.7%) |
| Sept 2016 | - | $15.68 M(-10.8%) |
| June 2016 | - | $17.58 M(-9.7%) |
| Mar 2016 | - | $19.46 M(-31.4%) |
| Dec 2015 | $28.36 M(+57.7%) | $28.36 M(+47.0%) |
| Sept 2015 | - | $19.29 M(+76.1%) |
| June 2015 | - | $10.95 M(-33.6%) |
| Mar 2015 | - | $16.49 M(-8.3%) |
| Dec 2014 | $17.98 M(+63.4%) | $17.98 M(+15.1%) |
| Sept 2014 | - | $15.63 M(+16.2%) |
| June 2014 | - | $13.45 M(+36.3%) |
| Mar 2014 | - | $9.87 M(-10.4%) |
| Dec 2013 | $11.01 M(+7.5%) | $11.01 M(+25.4%) |
| Sept 2013 | - | $8.78 M(-7.2%) |
| June 2013 | - | $9.46 M(+75.7%) |
| Mar 2013 | - | $5.38 M(-47.4%) |
| Dec 2012 | $10.24 M(+23.4%) | $10.24 M(+94.8%) |
| Sept 2012 | - | $5.26 M(-15.1%) |
| June 2012 | - | $6.19 M(+15.9%) |
| Mar 2012 | - | $5.34 M(-35.6%) |
| Dec 2011 | $8.30 M(+27.2%) | $8.30 M(+24.8%) |
| Sept 2011 | - | $6.65 M(+116.6%) |
| June 2011 | - | $3.07 M(-34.0%) |
| Mar 2011 | - | $4.65 M(-28.7%) |
| Dec 2010 | $6.52 M(+38.9%) | $6.52 M(+92.3%) |
| Sept 2010 | - | $3.39 M(-36.7%) |
| June 2010 | - | $5.36 M(+10.6%) |
| Mar 2010 | - | $4.84 M(+3.1%) |
| Dec 2009 | $4.70 M(-17.8%) | $4.70 M(-15.4%) |
| Sept 2009 | - | $5.55 M(-16.6%) |
| June 2009 | - | $6.66 M(-10.6%) |
| Mar 2009 | - | $7.45 M(+30.4%) |
| Dec 2008 | $5.71 M(+26.7%) | $5.71 M(-17.1%) |
| Sept 2008 | - | $6.88 M(+20.5%) |
| June 2008 | - | $5.72 M(+1.5%) |
| Mar 2008 | - | $5.63 M(+25.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2007 | $4.51 M(+5.1%) | $4.51 M(0.0%) |
| Sept 2007 | - | $4.51 M(+8.3%) |
| June 2007 | - | $4.16 M(+27.1%) |
| Mar 2007 | - | $3.27 M(-23.6%) |
| Dec 2006 | $4.29 M(+104.7%) | $4.29 M(+42.8%) |
| Sept 2006 | - | $3.00 M(-8.1%) |
| June 2006 | - | $3.27 M(+31.6%) |
| Mar 2006 | - | $2.48 M(+18.5%) |
| Dec 2005 | $2.10 M(-69.9%) | $2.10 M(-26.1%) |
| Sept 2005 | - | $2.83 M(+23.3%) |
| June 2005 | - | $2.30 M(+2.5%) |
| Mar 2005 | - | $2.24 M(-67.8%) |
| Dec 2004 | $6.97 M(+87.3%) | $6.97 M(+147.2%) |
| Sept 2004 | - | $2.82 M(-17.5%) |
| June 2004 | - | $3.42 M(+2.0%) |
| Mar 2004 | - | $3.35 M(-10.0%) |
| Dec 2003 | $3.72 M(-32.7%) | $3.72 M(+71.3%) |
| Sept 2003 | - | $2.17 M(-42.6%) |
| June 2003 | - | $3.78 M(+30.9%) |
| Mar 2003 | - | $2.89 M(-47.7%) |
| Dec 2002 | $5.52 M(-9.8%) | $5.52 M(-51.5%) |
| Sept 2002 | - | $11.38 M(+256.0%) |
| June 2002 | - | $3.20 M(-44.9%) |
| Mar 2002 | - | $5.80 M(-5.3%) |
| Dec 2001 | $6.13 M(+174.6%) | $6.13 M(+107.7%) |
| Sept 2001 | - | $2.95 M(+5.1%) |
| June 2001 | - | $2.81 M(-15.7%) |
| Mar 2001 | - | $3.33 M(+49.2%) |
| Dec 2000 | $2.23 M(-28.0%) | $2.23 M(+204.8%) |
| Sept 2000 | - | $732.00 K(-35.4%) |
| June 2000 | - | $1.13 M(-12.9%) |
| Mar 2000 | - | $1.30 M(-58.0%) |
| Dec 1999 | $3.10 M(+3.3%) | $3.10 M(+72.2%) |
| Sept 1999 | - | $1.80 M(-33.3%) |
| June 1999 | - | $2.70 M(0.0%) |
| Mar 1999 | - | $2.70 M(-10.0%) |
| Dec 1998 | $3.00 M(+7.1%) | $3.00 M(+7.1%) |
| Sept 1998 | - | $2.80 M(+3.7%) |
| June 1998 | - | $2.70 M(+125.0%) |
| Mar 1998 | - | $1.20 M(-57.1%) |
| Dec 1997 | $2.80 M(+16.7%) | $2.80 M(+154.5%) |
| Sept 1997 | - | $1.10 M(-21.4%) |
| June 1997 | - | $1.40 M(-41.7%) |
| Mar 1997 | - | $2.40 M(0.0%) |
| Dec 1996 | $2.40 M(+140.0%) | $2.40 M(+166.7%) |
| Sept 1996 | - | $900.00 K(+28.6%) |
| June 1996 | - | $700.00 K(-36.4%) |
| Mar 1996 | - | $1.10 M(+10.0%) |
| Dec 1995 | $1.00 M(-33.3%) | $1.00 M(+25.0%) |
| Sept 1995 | - | $800.00 K(+33.3%) |
| June 1995 | - | $600.00 K(-57.1%) |
| Mar 1995 | - | $1.40 M(-6.7%) |
| Dec 1994 | $1.50 M(+7.1%) | $1.50 M(+15.4%) |
| Sept 1994 | - | $1.30 M(+30.0%) |
| June 1994 | - | $1.00 M(+11.1%) |
| Mar 1994 | - | $900.00 K(-35.7%) |
| Dec 1993 | $1.40 M(+40.0%) | $1.40 M(+55.6%) |
| Sept 1993 | - | $900.00 K(+80.0%) |
| June 1993 | - | $500.00 K(-16.7%) |
| Mar 1993 | - | $600.00 K(-40.0%) |
| Dec 1992 | $1.00 M(-16.7%) | $1.00 M(+66.7%) |
| Sept 1992 | - | $600.00 K(-25.0%) |
| June 1992 | - | $800.00 K(-38.5%) |
| Mar 1992 | - | $1.30 M(+8.3%) |
| Dec 1991 | $1.20 M | $1.20 M(+200.0%) |
| Sept 1991 | - | $400.00 K(-69.2%) |
| June 1991 | - | $1.30 M(+225.0%) |
| Mar 1991 | - | $400.00 K |
FAQ
- What is Ionis Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for Ionis Pharmaceuticals?
- What is Ionis Pharmaceuticals annual accounts payable year-on-year change?
- What is Ionis Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for Ionis Pharmaceuticals?
- What is Ionis Pharmaceuticals quarterly accounts payable year-on-year change?
What is Ionis Pharmaceuticals annual accounts payable?
The current annual accounts payable of IONS is $26.03 M
What is the all time high annual accounts payable for Ionis Pharmaceuticals?
Ionis Pharmaceuticals all-time high annual accounts payable is $28.66 M
What is Ionis Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, IONS annual accounts payable has changed by +$8.11 M (+45.23%)
What is Ionis Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of IONS is $9.05 M
What is the all time high quarterly accounts payable for Ionis Pharmaceuticals?
Ionis Pharmaceuticals all-time high quarterly accounts payable is $28.66 M
What is Ionis Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, IONS quarterly accounts payable has changed by +$3.44 M (+61.21%)